I-Corps: Non-invasive intracranial pressure sensing

I-Corps：无创颅内压传感

• 批准号: 2321547
• 负责人: Jana Kainerstorfer
• 金额: $ 5万
• 依托单位: Carnegie-Mellon University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2023-10-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2321547&HistoricalAwards=false
• 关键词: Corps; Non; invasive; intracranial; pressure

The broader impact/commercial potential of this I-Corps project is the development of a non-invasive method for monitoring intracranial pressure through near-infrared spectroscopy. The current invasive method for measuring intracranial pressure carries a high risk of complications and is not accessible to all patients. The proposed technology aims to provide a cost-effective and easily accessible alternative to the current method. This technology has the potential to improve patient outcomes by enabling early detection of elevated intracranial pressure, thereby allowing for early intervention. The project aims to identify the commercial viability of this technology and explore the potential markets and regulatory processes both domestically and abroad.This I-Corps project is based on the development of a non-invasive alternative to the current invasive method of measuring intracranial pressure. The proposed technology, based on near-infrared spectroscopy, has the potential to significantly improve patient outcomes by enabling early detection of elevated intracranial pressure. This technology uses an optical sensor placed on the forehead of the patient. The project aims to clarify the beachhead market within neurocritical care centers and the attractiveness of markets and regulatory processes abroad.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

I-Corps项目的更广泛影响/商业潜力是开发一种通过近红外光谱监测颅内压的非侵入性方法。目前用于测量颅内压的侵入性方法具有高并发症风险，并且并非所有患者都可以使用。拟议的技术旨在提供一种具有成本效益且易于获得的替代方法。该技术有可能通过早期检测颅内压升高来改善患者结局，从而允许早期干预。该项目旨在确定该技术的商业可行性，并探索国内外的潜在市场和监管流程。该I-Corps项目基于开发一种非侵入性替代方法来测量颅内压。基于近红外光谱的拟议技术有可能通过早期检测颅内压升高来显着改善患者的预后。该技术使用放置在患者前额上的光学传感器。该项目旨在明确神经重症监护中心的滩头阵地市场以及国外市场和监管流程的吸引力。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。